---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038547"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:05:46.452531+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio revises CEO/CFO J.D. Finley's employment agreement; salary unchanged

## Summary
- Base salary stays at $542,000 per year; target bonus remains up to 50% of base.
- Non-CIC severance: 12 months base salary continuation plus COBRA premiums.
- CIC severance: lump sum of 18 months base plus 100% target bonus, 18 months COBRA, full acceleration of time-based equity.
- Agreement is at-will; executive must sign release for severance benefits.

## SEC filing metadata
- accession: 0001493152-24-038547
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315224038547/0001493152-24-038547-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315224038547/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038547
- JSON: https://secwatch.observer/filing/0001493152-24-038547.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038547.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.